These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26652481)

  • 1. Utility of Leflunomide in the Treatment of Drug Resistant Cytomegalovirus Retinitis.
    Rifkin LM; Minkus CL; Pursell K; Jumroendararasame C; Goldstein DA
    Ocul Immunol Inflamm; 2017 Feb; 25(1):93-96. PubMed ID: 26652481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Ganciclovir Resistant Cytomegalovirus Retinitis in a Solid Organ Transplant Recipient: A Review of Current Evidence and Treatment Approaches.
    Fu L; Santhanakrishnan K; Al-Aloul M; Jones NP; Steeples LR
    Ocul Immunol Inflamm; 2020 Oct; 28(7):1152-1158. PubMed ID: 31621449
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of multidrug-resistant cytomegalovirus retinitis with systemically administered leflunomide.
    Levi ME; Mandava N; Chan LK; Weinberg A; Olson JL
    Transpl Infect Dis; 2006 Mar; 8(1):38-43. PubMed ID: 16623819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term suppression of multidrug-resistant cytomegalovirus retinitis with systemically administered leflunomide.
    Dunn JH; Weinberg A; Chan LK; Mandava N; Levi ME; Olson JL
    JAMA Ophthalmol; 2013 Jul; 131(7):958-60. PubMed ID: 23846207
    [No Abstract]   [Full Text] [Related]  

  • 5. Leflunomide as a rescue treatment in ganciclovir-resistant cytomegalovirus infection in a seronegative renal transplant recipient--a case report.
    Ciszek M; Mucha K; Foroncewicz B; Chmura A; Pączek L
    Ann Transplant; 2014 Jan; 19():60-3. PubMed ID: 24481271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leflunomide as part of the treatment for multidrug-resistant cytomegalovirus disease after lung transplantation: case report and review of the literature.
    Verkaik NJ; Hoek RA; van Bergeijk H; van Hal PT; Schipper ME; Pas SD; Beersma MF; Boucher CA; Jedema I; Falkenburg F; Hoogsteden HC; van den Blink B; Murk JL
    Transpl Infect Dis; 2013 Dec; 15(6):E243-9. PubMed ID: 24298985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of leflunomide in the treatment of complex cytomegalovirus syndromes.
    Avery RK; Mossad SB; Poggio E; Lard M; Budev M; Bolwell B; Waldman WJ; Braun W; Mawhorter SD; Fatica R; Krishnamurthi V; Young JB; Shrestha R; Stephany B; Lurain N; Yen-Lieberman B
    Transplantation; 2010 Aug; 90(4):419-26. PubMed ID: 20683281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of leflunomide in a cytomegalovirus infection resistant: a report of a case].
    Gómez Valbuena I; Alioto D; Serrano Garrote O; Ferrari Piquero JM
    Farm Hosp; 2016 Jan; 40(1):52-4. PubMed ID: 26882834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with leflunomide as treatment and as secondary prophylaxis for cytomegalovirus infection in lung transplant recipients: A case series and review of the literature.
    Silva JT; Pérez-González V; Lopez-Medrano F; Alonso-Moralejo R; Fernández-Ruiz M; San-Juan R; Brañas P; Folgueira MD; Aguado JM; de Pablo-Gafas A
    Clin Transplant; 2018 Feb; 32(2):. PubMed ID: 29226391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent CMV retinitis in a non-HIV patient with drug-resistant CMV.
    Hoang QV; Simon DM; Kumar GN; Oh F; Goldstein DA
    Graefes Arch Clin Exp Ophthalmol; 2010 May; 248(5):737-40. PubMed ID: 20094728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients.
    Myhre HA; Haug Dorenberg D; Kristiansen KI; Rollag H; Leivestad T; Asberg A; Hartmann A
    Transplantation; 2011 Jul; 92(2):217-23. PubMed ID: 21685829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection.
    Avery RK; Bolwell BJ; Yen-Lieberman B; Lurain N; Waldman WJ; Longworth DL; Taege AJ; Mossad SB; Kohn D; Long JR; Curtis J; Kalaycio M; Pohlman B; Williams JW
    Bone Marrow Transplant; 2004 Dec; 34(12):1071-5. PubMed ID: 15489872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus Infection and Rates of Antiviral Resistance Following Intestinal and Multivisceral Transplantation.
    Ambrose T; Sharkey LM; Louis-Auguste J; Rutter CS; Duncan S; English S; Gkrania-Klotsas E; Carmichael A; Woodward JM; Russell N; Massey D; Butler A; Middleton S
    Transplant Proc; 2016 Mar; 48(2):492-6. PubMed ID: 27109985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganciclovir-resistant cytomegalovirus infections among lung transplant recipients are associated with poor outcomes despite treatment with foscarnet-containing regimens.
    Minces LR; Nguyen MH; Mitsani D; Shields RK; Kwak EJ; Silveira FP; Abdel-Massih R; Pilewski JM; Crespo MM; Bermudez C; Bhama JK; Toyoda Y; Clancy CJ
    Antimicrob Agents Chemother; 2014; 58(1):128-35. PubMed ID: 24145525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of ganciclovir versus foscarnet in ganciclovir-resistant cytomegalovirus retinitis: A case report.
    Lee HJ; Woo SJ
    Eur J Ophthalmol; 2023 Sep; 33(5):NP105-NP108. PubMed ID: 36314436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of refractory CMV-infection following hematopoietic stem cell transplantation with the combination of foscarnet and leflunomide.
    Ehlert K; Groll AH; Kuehn J; Vormoor J
    Klin Padiatr; 2006; 218(3):180-4. PubMed ID: 16688677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual Intravitreal Injections With Foscarnet and Ganciclovir for Ganciclovir-Resistant Recurrent Cytomegalovirus Retinitis in a Congenitally Infected Infant.
    Boss JD; Rosenberg K; Shah R
    J Pediatr Ophthalmol Strabismus; 2016 Oct; 53():e58-e60. PubMed ID: 27783090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment with foscarnet for ganciclovir-resistant cytomegalovirus infection in a kidney transplant recipient: A case report.
    Iwami D; Ogawa Y; Fujita H; Morita K; Sasaki H; Oishi Y; Higuchi H; Hatanaka K; Shinohara N
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():63-6. PubMed ID: 26970406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective evaluation of leflunomide therapy for cytomegalovirus disease in renal transplant recipients.
    John GT; Manivannan J; Chandy S; Peter S; Fleming DH; Chandy SJ; Balakrishnan N; Krishnamurthy K; Kirubakaran MG; Jacob CK
    Transplant Proc; 2005 Dec; 37(10):4303-5. PubMed ID: 16387103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus Retinitis in a Human Immunodeficiency Virus-negative Cohort: Long-term Management and Complications.
    Jeon S; Lee WK
    Ocul Immunol Inflamm; 2015; 23(5):392-9. PubMed ID: 25760914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.